151 related articles for article (PubMed ID: 23462182)
21. WAC Promotes Polo-like Kinase 1 Activation for Timely Mitotic Entry.
Qi F; Chen Q; Chen H; Yan H; Chen B; Xiang X; Liang C; Yi Q; Zhang M; Cheng H; Zhang Z; Huang J; Wang F
Cell Rep; 2018 Jul; 24(3):546-556. PubMed ID: 30021153
[TBL] [Abstract][Full Text] [Related]
22. Female infertility in PDE3A(-/-) mice: polo-like kinase 1 (Plk1) may be a target of protein kinase A (PKA) and involved in meiotic arrest of oocytes from PDE3A(-/-) mice.
Shen W; Ahmad F; Hockman S; Ma J; Omi H; Raghavachari N; Manganiello V
Cell Cycle; 2010 Dec; 9(23):4720-34. PubMed ID: 21099356
[TBL] [Abstract][Full Text] [Related]
23. Sequential phosphorylation of Nedd1 by Cdk1 and Plk1 is required for targeting of the gammaTuRC to the centrosome.
Zhang X; Chen Q; Feng J; Hou J; Yang F; Liu J; Jiang Q; Zhang C
J Cell Sci; 2009 Jul; 122(Pt 13):2240-51. PubMed ID: 19509060
[TBL] [Abstract][Full Text] [Related]
24. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.
Moshe Y; Boulaire J; Pagano M; Hershko A
Proc Natl Acad Sci U S A; 2004 May; 101(21):7937-42. PubMed ID: 15148369
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest.
Harley ME; Allan LA; Sanderson HS; Clarke PR
EMBO J; 2010 Jul; 29(14):2407-20. PubMed ID: 20526282
[TBL] [Abstract][Full Text] [Related]
26. Mitotic inhibition of GRASP65 organelle tethering involves Polo-like kinase 1 (PLK1) phosphorylation proximate to an internal PDZ ligand.
Sengupta D; Linstedt AD
J Biol Chem; 2010 Dec; 285(51):39994-40003. PubMed ID: 20937827
[TBL] [Abstract][Full Text] [Related]
27. G
Giráldez S; Galindo-Moreno M; Limón-Mortés MC; Rivas AC; Herrero-Ruiz J; Mora-Santos M; Sáez C; Japón MÁ; Tortolero M; Romero F
FASEB J; 2017 Jul; 31(7):2925-2936. PubMed ID: 28360195
[TBL] [Abstract][Full Text] [Related]
28. Furry protein promotes aurora A-mediated Polo-like kinase 1 activation.
Ikeda M; Chiba S; Ohashi K; Mizuno K
J Biol Chem; 2012 Aug; 287(33):27670-81. PubMed ID: 22753416
[TBL] [Abstract][Full Text] [Related]
29. The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
de Cárcer G
Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30862113
[TBL] [Abstract][Full Text] [Related]
30. A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint.
van Vugt MA; Gardino AK; Linding R; Ostheimer GJ; Reinhardt HC; Ong SE; Tan CS; Miao H; Keezer SM; Li J; Pawson T; Lewis TA; Carr SA; Smerdon SJ; Brummelkamp TR; Yaffe MB
PLoS Biol; 2010 Jan; 8(1):e1000287. PubMed ID: 20126263
[TBL] [Abstract][Full Text] [Related]
31. A predictive mathematical model of the DNA damage G2 checkpoint.
Kesseler KJ; Blinov ML; Elston TC; Kaufmann WK; Simpson DA
J Theor Biol; 2013 Mar; 320():159-69. PubMed ID: 23266715
[TBL] [Abstract][Full Text] [Related]
32.
Liu C; Shi Y; Li J; Liu X; Xiahou Z; Tan Z; Chen X; Li J
J Biol Chem; 2020 May; 295(21):7341-7349. PubMed ID: 32295844
[TBL] [Abstract][Full Text] [Related]
33. Interaction of Sororin protein with polo-like kinase 1 mediates resolution of chromosomal arm cohesion.
Zhang N; Panigrahi AK; Mao Q; Pati D
J Biol Chem; 2011 Dec; 286(48):41826-41837. PubMed ID: 21987589
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of action of the multikinase inhibitor Foretinib.
Dufies M; Jacquel A; Robert G; Cluzeau T; Puissant A; Fenouille N; Legros L; Raynaud S; Cassuto JP; Luciano F; Auberger P
Cell Cycle; 2011 Dec; 10(23):4138-48. PubMed ID: 22101270
[TBL] [Abstract][Full Text] [Related]
35. Purification and proteomic identification of putative upstream regulators of polo-like kinase-1 from mitotic cell extracts.
Ji JH; Hwang HI; Lee HJ; Hyun SY; Kang HJ; Jang YJ
FEBS Lett; 2010 Oct; 584(20):4299-305. PubMed ID: 20869364
[TBL] [Abstract][Full Text] [Related]
36. Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis.
Fabbro M; Zhou BB; Takahashi M; Sarcevic B; Lal P; Graham ME; Gabrielli BG; Robinson PJ; Nigg EA; Ono Y; Khanna KK
Dev Cell; 2005 Oct; 9(4):477-88. PubMed ID: 16198290
[TBL] [Abstract][Full Text] [Related]
37. Autoinhibition and Polo-dependent multisite phosphorylation restrict activity of the histone H3 kinase Haspin to mitosis.
Ghenoiu C; Wheelock MS; Funabiki H
Mol Cell; 2013 Dec; 52(5):734-45. PubMed ID: 24184212
[TBL] [Abstract][Full Text] [Related]
38. CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension.
Pal-Ghosh R; Xue D; Warburton R; Hill N; Polgar P; Wilson JL
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203295
[TBL] [Abstract][Full Text] [Related]
39. Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.
Kettenbach AN; Schweppe DK; Faherty BK; Pechenick D; Pletnev AA; Gerber SA
Sci Signal; 2011 Jun; 4(179):rs5. PubMed ID: 21712546
[TBL] [Abstract][Full Text] [Related]
40. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.
Deming PB; Flores KG; Downes CS; Paules RS; Kaufmann WK
J Biol Chem; 2002 Sep; 277(39):36832-8. PubMed ID: 12147700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
